HomeProductsBuilding BlocksHeterocyclic ScaffoldsPiperidinesAvadomide
Chemical structure of CAS 1015474-32-4

Avadomide

CAS No.1015474-32-4
MDL No.MFCD29919294
MFC14H14N4O3
MW286.29
InChI KeyRSNPAKAFCAAMBH-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1015474-32-4
Product NameAvadomide

Associated Conditions

chronic lymphocytic leukemia·follicular lymphoma·hepatocellular carcinoma·diffuse large B-cell lymphoma·Renal insufficiency·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 25, Issue 1 • 2019
PMID: 30201761DOI: 10.1158/1078-0432.CCR-18-1203

CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.

Blood • Vol. 126, Issue 6 • 2015
PMID: 26002965PMC: PMC4528065DOI: 10.1182/blood-2015-02-628669

Documentation

Similar Products